HEPATIC IMPAIRMENT AND HEALTHY FEMALE
Clinical trials for HEPATIC IMPAIRMENT AND HEALTHY FEMALE explained in plain language.
Never miss a new study
Get alerted when new HEPATIC IMPAIRMENT AND HEALTHY FEMALE trials appear
Sign up with your email to follow new studies for HEPATIC IMPAIRMENT AND HEALTHY FEMALE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver function study tests new drug processing
Knowledge-focused Not yet recruitingThis early-stage study looks at how a single 25 mg dose of VC005 tablets is handled by the body in people with mild or moderate liver impairment compared to those with normal liver function. The goal is to measure drug levels and safety, not to treat the liver condition. 24 adult…
Matched conditions: HEPATIC IMPAIRMENT AND HEALTHY FEMALE
Phase: PHASE1 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Knowledge-focused
Last updated May 11, 2026 20:52 UTC
-
Liver health and drug processing: new study on GS1-144
Knowledge-focused Not yet recruitingThis early-stage study looks at how the drug GS1-144 moves through the bodies of women with liver problems compared to healthy women. About 24 women aged 18-70 will take part. The goal is to understand how liver health affects drug levels, not to treat any condition.
Matched conditions: HEPATIC IMPAIRMENT AND HEALTHY FEMALE
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 08, 2026 12:04 UTC